USD 8.36 billion
Immunoprotein Diagnostic Testing Market Size, Share, Growth Analysis, By Product(Immunoglobulins, complement system proteins, and prealbumin), By Application(Infectious diseases, oncology, autoimmune disorders, and allergy testingSegmentEnd-userSub-SegmentsHospitals), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2600 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
66
|Figures:
75
Immunoprotein Diagnostic Testing Market Insights
Immunoprotein Diagnostic Testing Market size was valued at USD 8.36 billion in 2022 and is poised to grow from USD 8.96 billion in 2023 to USD 14.58 billion by 2030, at a CAGR of 7.2% during the forecast period (2023-2030).
The global immunoprotein diagnostic testing market has exhibited significant growth due to rising incidences of infectious and chronic diseases, coupled with a growing awareness about early disease detection.
Technological advancements in diagnostic techniques, such as enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays, have led to improved accuracy and efficiency in protein-based diagnostics.
Additionally, the increasing geriatric population and healthcare expenditure have further propelled market expansion. However, cost constraints and stringent regulatory requirements could potentially impede market growth.
Overall, the market is driven by the increasing demand for accurate and rapid diagnostic tools to aid in effective disease management and therapeutic decision-making.
US Immunoprotein Diagnostic Testing Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
7.2% CAGR
Global Immunoprotein Diagnostic Testing Market by region
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Immunoprotein Diagnostic Testing Market Segmental Analysis
The global immunoprotein diagnostic testing market can be segmented based on type, application, end user, and region. By type, the market includes immunoglobulins, complement system proteins, and prealbumin. In terms of application, the segments comprise infectious diseases, oncology, autoimmune disorders, and allergy testing. End users involve hospitals, clinical laboratories, and research centers. Geographically, the market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Immunoprotein Diagnostic Testing Market Analysis By Product
Immunoglobulins constitute the largest sector in the immunoprotein diagnostic testing market due to their essential role in identifying and diagnosing a wide range of diseases and conditions.
On the other hand, the fastest growing sector in this market is the complement system proteins segment. Complement system proteins are vital components of the immune system that assist in the destruction of pathogens and other harmful agents.
Immunoprotein Diagnostic Testing Market Analysis By Application
The largest sector is infectious diseases, which involves the detection of various pathogens such as bacteria and viruses that cause infections. This is crucial for timely diagnosis and effective treatment planning.
The fastest growing sector, however, is oncology, focusing on the diagnosis and monitoring of different types of cancers through immunoprotein biomarkers. The increasing prevalence of cancer and the growing demand for accurate and early-stage cancer diagnosis have fueled the expansion of this segment.
Global Immunoprotein Diagnostic Testing Market by end user
To get detailed analysis on other segments, Request For Free Sample Report
Immunoprotein Diagnostic Testing Market Regional Insights
The global immunoprotein diagnostic testing market exhibits diverse regional trends. North America commands a significant share due to advanced healthcare infrastructure and high R&D investments. Europe follows suit with a strong emphasis on early disease detection and a growing elderly population. In Asia, rapid urbanization and increasing healthcare expenditure propel market growth, while Latin America and the Middle East display rising awareness about diagnostic advancements. Africa lags behind due to limited access to advanced healthcare facilities. Overall, the market's trajectory varies across regions, shaped by factors such as economic development, healthcare policies, and technological adoption.
Global Immunoprotein Diagnostic Testing Market by geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Immunoprotein Diagnostic Testing Market Dynamics
Immunoprotein Diagnostic Testing Market Drivers
Demand for Dealing with Chronic Diseases
- One driver of the global immunoprotein diagnostic testing market is the increasing prevalence of infectious and chronic diseases, propelling the demand for accurate and timely diagnosis. Immunoprotein tests play a crucial role in identifying conditions such as cancer, autoimmune disorders, and infectious diseases. The rising awareness of early disease detection and the development of advanced diagnostic technologies are further fueling market growth.
Immunoprotein Diagnostic Testing Market Restraints
Cost Complexity
- A significant restraint for the market is the complexity and cost of developing and implementing immunoprotein diagnostic tests. The development of reliable and specific tests requires substantial research, development, and validation processes, which can be time-consuming and resource intensive. Moreover, the affordability and accessibility of these tests can pose challenges in resource-limited healthcare settings, hindering their widespread adoption and potentially limiting market expansion.
Request Free Customization of this report to help us to meet your business objectives.
Immunoprotein Diagnostic Testing Market Competitive Landscape
The global immunoprotein diagnostic testing market's competitive landscape features a dynamic interplay of established players and innovative entrants striving to capture market share. Key industry participants such as Roche Diagnostics, Abbott Laboratories, and Siemens Healthineers continue to dominate with their comprehensive product portfolios, extensive distribution networks, and strong R&D capabilities. However, emerging companies like Bio-Rad Laboratories and Ortho Clinical Diagnostics are gaining traction by focusing on novel technologies, strategic collaborations, and niche diagnostic solutions, intensifying competition and fostering technological advancements in immunoprotein diagnostic testing.
Immunoprotein Diagnostic Testing Market Top Player’s Company Profiles
- Roche Diagnostics - Switzerland
- Abbott Laboratories - United States
- Siemens Healthineers - Germany
- Thermo Fisher Scientific - United States
- Bio-Rad Laboratories - United States
- Ortho Clinical Diagnostics - United States
- Beckman Coulter (a subsidiary of Danaher Corporation) - United States
- DiaSorin - Italy
- Becton, Dickinson and Company (BD) - United States
- Sysmex Corporation - Japan
- Randox Laboratories - United Kingdom
- QIAGEN - Netherlands
- Fujirebio (a subsidiary of Miraca Holdings Inc.) - Japan
- BioMérieux - France
- Grifols - Spain
- Werfen - Spain
- Meridian Bioscience - United States
- Luminex Corporation - United States
- Bio-Techne Corporation - United States
- EUROIMMUN (a subsidiary of PerkinElmer) - Germany
Immunoprotein Diagnostic Testing Market Recent Developments
- In July 2022, Indirect Immunofluorescence (IIF) serum blood testing for laminin 332, an antigen linked to the chronic, crippling autoimmune condition mucous membrane pemphigoid (MMP), was first made available in the US by KSL Beutner Laboratories.
- In April 2022, A first-of-its-kind antibody test that measures the risk of infection after exposure to COVID-19 was introduced by KSL Diagnostics, Inc.
Immunoprotein Diagnostic Testing Key Market Trends
- The global immunoprotein diagnostic testing market is witnessing significant trends that are shaping its landscape. The increasing prevalence of infectious and chronic diseases is driving the demand for accurate and efficient diagnostic tools, leading to the expansion of the immunoprotein testing market. Technological advancements, such as the development of multiplex immunoassay platforms and point-of-care testing options, are enabling rapid and precise results. Moreover, the growing focus on personalized medicine and biomarker research is further propelling the adoption of immunoprotein diagnostic tests. Additionally, collaborations between industry players and research institutions are fostering innovation and driving market growth.
Immunoprotein Diagnostic Testing Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global immunoprotein diagnostic testing market is poised for promising future prospects as advancements in technology continue to drive innovation in diagnostic methods. The increasing prevalence of infectious and chronic diseases, coupled with a growing aging population, is anticipated to fuel the demand for accurate and efficient immunoprotein-based diagnostic tests. These tests offer a critical tool for early disease detection, monitoring therapeutic efficacy, and guiding treatment decisions. Moreover, ongoing research in biomarker identification and personalized medicine is likely to enhance the precision and scope of immunoprotein diagnostics. Market expansion will be further propelled by rising healthcare expenditure, improved accessibility to healthcare services in developing regions, and a heightened emphasis on preventive healthcare. However, challenges related to regulatory approvals, cost-effectiveness, and the need for skilled professionals might influence market dynamics.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 8.36 billion |
| Market size value in 2031 | USD 14.58 billion |
| Growth Rate | 7.2% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Immunoprotein Diagnostic Testing Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Immunoprotein Diagnostic Testing Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Immunoprotein Diagnostic Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Immunoprotein Diagnostic Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Immunoprotein Diagnostic Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Immunoprotein Diagnostic Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
